STOCK TITAN

[Form 4] Teradyne, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Mercedes Johnson, a director of Teradyne, Inc. (TER), reported a sale of company stock under a pre-established trading plan. The Form 4 shows a transaction on 09/05/2025 in which 625 shares of Teradyne common stock were sold at a price of $120.06 per share. After the sale, the reporting person directly beneficially owned 10,738 shares and indirectly beneficially owned 1,876 shares held by a trust for which she is trustee and sole beneficiary.

The filing notes the sale was made pursuant to a 10b5-1 plan adopted on February 3, 2025. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 09/09/2025.

Mercedes Johnson, membro del consiglio di amministrazione di Teradyne, Inc. (TER), ha venduto azioni della società nell'ambito di un piano di trading predefinito. Il Modulo 4 riporta una transazione del 05/09/2025 nella quale sono state vendute 625 azioni ordinarie Teradyne al prezzo di $120,06 per azione. Dopo la vendita, la dichiarante possedeva direttamente 10.738 azioni e beneficiava indirettamente di 1.876 azioni detenute da un trust per il quale è fiduciaria e unica beneficiaria.

La comunicazione specifica che la vendita è stata effettuata ai sensi di un piano 10b5-1 adottato il 3 febbraio 2025. Il Modulo 4 è stato firmato da un procuratore il 09/09/2025 per conto della dichiarante.

Mercedes Johnson, directora de Teradyne, Inc. (TER), informó la venta de acciones de la compañía bajo un plan de trading preestablecido. El Formulario 4 muestra una transacción del 05/09/2025 en la que se vendieron 625 acciones ordinarias de Teradyne a $120.06 por acción. Tras la venta, la informante poseía directamente 10.738 acciones y de forma indirecta 1.876 acciones mantenidas en un fideicomiso del que es fiduciaria y única beneficiaria.

La presentación indica que la venta se realizó conforme a un plan 10b5-1 adoptado el 3 de febrero de 2025. El Formulario 4 fue firmado por un apoderado en nombre de la informante el 09/09/2025.

테라다인 주식회사(Teradyne, Inc., TER) 이사인 메르세데스 존슨은 사전에 설정된 거래 계획에 따라 자사 주식을 처분했다고 보고했습니다. Form 4에는 2025년 9월 5일자로 625주를 주당 $120.06에 매도한 거래가 기록되어 있습니다. 매도 후 보고인은 직접적으로 10,738주를 보유하고 있으며, 자신이 신탁 수탁자이자 유일한 수익자인 신탁에 의해 1,876주를 간접적으로 보유하고 있습니다.

신고서에는 해당 매각이 2025년 2월 3일 채택된 10b5-1 계획에 따라 이루어졌다고 명시되어 있습니다. Form 4는 2025년 9월 9일 보고인을 대신한 대리인이 서명했습니다.

Mercedes Johnson, administratrice de Teradyne, Inc. (TER), a déclaré la vente d'actions de la société dans le cadre d'un plan de trading préétabli. Le formulaire 4 indique une transaction en date du 05/09/2025 au cours de laquelle 625 actions ordinaires Teradyne ont été vendues au prix de 120,06 $ par action. Après la vente, la déclarente détenait directement 10 738 actions et bénéficiait indirectement de 1 876 actions détenues par une fiducie dont elle est la fiduciaire et l'unique bénéficiaire.

Le dépôt précise que la vente a été effectuée en vertu d'un plan 10b5-1 adopté le 3 février 2025. Le formulaire 4 a été signé le 09/09/2025 par un mandataire agissant pour le compte de la déclarente.

Mercedes Johnson, Direktorin von Teradyne, Inc. (TER), meldete den Verkauf von Unternehmensaktien im Rahmen eines vorab festgelegten Handelsplans. Das Formular 4 weist eine Transaktion vom 05.09.2025 aus, bei der 625 Stammaktien von Teradyne zu einem Preis von $120,06 je Aktie verkauft wurden. Nach dem Verkauf besaß die meldepflichtige Person direkt 10.738 Aktien und indirekt 1.876 Aktien, die von einem Trust gehalten werden, bei dem sie Treuhänderin und alleinige Begünstigte ist.

Die Einreichung weist darauf hin, dass der Verkauf gemäß einem am 3. Februar 2025 angenommenen 10b5-1-Plan erfolgte. Das Formular 4 wurde am 09.09.2025 von einem Bevollmächtigten im Namen der meldepflichtigen Person unterschrieben.

Positive
  • Sale executed under a documented 10b5-1 plan adopted 02/03/2025, which supports compliance with insider trading rules
  • Full disclosure of direct and indirect holdings, including trust ownership and quantities after the transaction
  • Form 4 was timely signed and filed (signed by attorney-in-fact on 09/09/2025)
Negative
  • Reporting person sold 625 shares, reducing direct beneficial ownership
  • Transaction may be perceived as insider selling by some investors despite being under a 10b5-1 plan

Insights

TL;DR: Director sold a small block under a Rule 10b5-1 plan; ownership remains concentrated via direct and trust holdings.

The reported sale of 625 shares at $120.06 appears to be an execution under an existing 10b5-1 plan, which provides an affirmative defense to insider trading claims when properly adopted and operated. The director retains 10,738 shares directly and 1,876 shares indirectly through a trust, so the transaction reduced but did not eliminate her stake. This is a routine disclosure; there is no indication of unusual timing or departure from the plan in the filing itself.

TL;DR: Governance process followed: sale executed under documented plan and disclosed via Form 4.

The filing documents compliance with required reporting and indicates use of a documented trading plan adopted on 02/03/2025. The trust ownership disclosure clarifies indirect beneficial ownership, which supports transparency around potential conflicts. The signature by an attorney-in-fact is properly noted. From a governance perspective, this filing reflects standard insider disclosure practices rather than a material corporate event.

Mercedes Johnson, membro del consiglio di amministrazione di Teradyne, Inc. (TER), ha venduto azioni della società nell'ambito di un piano di trading predefinito. Il Modulo 4 riporta una transazione del 05/09/2025 nella quale sono state vendute 625 azioni ordinarie Teradyne al prezzo di $120,06 per azione. Dopo la vendita, la dichiarante possedeva direttamente 10.738 azioni e beneficiava indirettamente di 1.876 azioni detenute da un trust per il quale è fiduciaria e unica beneficiaria.

La comunicazione specifica che la vendita è stata effettuata ai sensi di un piano 10b5-1 adottato il 3 febbraio 2025. Il Modulo 4 è stato firmato da un procuratore il 09/09/2025 per conto della dichiarante.

Mercedes Johnson, directora de Teradyne, Inc. (TER), informó la venta de acciones de la compañía bajo un plan de trading preestablecido. El Formulario 4 muestra una transacción del 05/09/2025 en la que se vendieron 625 acciones ordinarias de Teradyne a $120.06 por acción. Tras la venta, la informante poseía directamente 10.738 acciones y de forma indirecta 1.876 acciones mantenidas en un fideicomiso del que es fiduciaria y única beneficiaria.

La presentación indica que la venta se realizó conforme a un plan 10b5-1 adoptado el 3 de febrero de 2025. El Formulario 4 fue firmado por un apoderado en nombre de la informante el 09/09/2025.

테라다인 주식회사(Teradyne, Inc., TER) 이사인 메르세데스 존슨은 사전에 설정된 거래 계획에 따라 자사 주식을 처분했다고 보고했습니다. Form 4에는 2025년 9월 5일자로 625주를 주당 $120.06에 매도한 거래가 기록되어 있습니다. 매도 후 보고인은 직접적으로 10,738주를 보유하고 있으며, 자신이 신탁 수탁자이자 유일한 수익자인 신탁에 의해 1,876주를 간접적으로 보유하고 있습니다.

신고서에는 해당 매각이 2025년 2월 3일 채택된 10b5-1 계획에 따라 이루어졌다고 명시되어 있습니다. Form 4는 2025년 9월 9일 보고인을 대신한 대리인이 서명했습니다.

Mercedes Johnson, administratrice de Teradyne, Inc. (TER), a déclaré la vente d'actions de la société dans le cadre d'un plan de trading préétabli. Le formulaire 4 indique une transaction en date du 05/09/2025 au cours de laquelle 625 actions ordinaires Teradyne ont été vendues au prix de 120,06 $ par action. Après la vente, la déclarente détenait directement 10 738 actions et bénéficiait indirectement de 1 876 actions détenues par une fiducie dont elle est la fiduciaire et l'unique bénéficiaire.

Le dépôt précise que la vente a été effectuée en vertu d'un plan 10b5-1 adopté le 3 février 2025. Le formulaire 4 a été signé le 09/09/2025 par un mandataire agissant pour le compte de la déclarente.

Mercedes Johnson, Direktorin von Teradyne, Inc. (TER), meldete den Verkauf von Unternehmensaktien im Rahmen eines vorab festgelegten Handelsplans. Das Formular 4 weist eine Transaktion vom 05.09.2025 aus, bei der 625 Stammaktien von Teradyne zu einem Preis von $120,06 je Aktie verkauft wurden. Nach dem Verkauf besaß die meldepflichtige Person direkt 10.738 Aktien und indirekt 1.876 Aktien, die von einem Trust gehalten werden, bei dem sie Treuhänderin und alleinige Begünstigte ist.

Die Einreichung weist darauf hin, dass der Verkauf gemäß einem am 3. Februar 2025 angenommenen 10b5-1-Plan erfolgte. Das Formular 4 wurde am 09.09.2025 von einem Bevollmächtigten im Namen der meldepflichtigen Person unterschrieben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
JOHNSON MERCEDES

(Last) (First) (Middle)
C/O TERADYNE, INC.
600 RIVERPARK DRIVE

(Street)
NORTH READING MA 01864

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
TERADYNE, INC [ TER ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/05/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/05/2025 S(1) 625 D $120.06 10,738 D
Common Stock 1,876 I By Trust(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The shares were sold pursuant to a sales plan adopted by the Reporting Person on February 3, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
2. Shares held by The Mercedes Johnson Trust UAD 07/23/04 (the "Trust"), of which the Reporting Person is the trustee and sole beneficiary.
/s/ Ryan E. Driscoll, Attorney-in-Fact 09/09/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Mercedes Johnson report on the Form 4 for TER?

The Form 4 reports a sale of 625 shares of Teradyne common stock on 09/05/2025 at a price of $120.06 per share.

Was the sale by the Teradyne director part of a 10b5-1 plan?

Yes. The filing states the shares were sold pursuant to a sales plan adopted on 02/03/2025 intended to comply with Rule 10b5-1.

How many Teradyne shares does Mercedes Johnson own after the transaction?

After the reported transaction, she directly beneficially owns 10,738 shares and indirectly owns 1,876 shares held by a trust.

What is the nature of the indirect ownership disclosed?

The indirect holdings are held by The Mercedes Johnson Trust UAD 07/23/04, of which the reporting person is the trustee and sole beneficiary.

When was the Form 4 signed and by whom?

The form is signed by an attorney-in-fact, Ryan E. Driscoll, on 09/09/2025 on behalf of the reporting person.
Teradyne

NASDAQ:TER

TER Rankings

TER Latest News

TER Latest SEC Filings

TER Stock Data

18.91B
158.63M
0.27%
103.94%
5%
Semiconductor Equipment & Materials
Instruments for Meas & Testing of Electricity & Elec Signals
Link
United States
NORTH READING